Ophthalmology Times Europe - Latest news in cataract, refractive, retina, glaucoma and more






Friday, 31 October 2014
Ophthalmology Times US - News
Newsletter sign-up
Aflibercept boosts BCVA in DME
October 31, 2014
Patients with diabetic macular oedema (DME) who received aflibercept injection demonstrated a significantly greater improvement in mean change in best-corrected visual acuity (BCVA) from baseline at 52 weeks compared to those who received either bevacizumab or ranibizumab.
Combination glaucoma drop moves toward approval
October 30, 2014
A preservative-free IOP-lowering eye drop that is a combination of tafluprost and timolol (Taptiqon, Santen) is seeking national licences in European countries after a positive decentralized procedure and a final assessment report from reference member state Germany, the Federal Institute for Drugs and Medical Devices of Germany, and agreement by concerned member states that the fixed-dose product is approvable.
Study examines link between MS and uveitis
October 29, 2014
The findings of a new study will enable clinicians to make more accurate diagnoses of multiple sclerosis (MS) and uveitis while giving people a better understanding of their prognoses, according to its authors.
UK charities drive retinal dystrophy consortium
October 24, 2014
UK sight loss charities RP Fighting Blindness and Fight for Sight are joining forces to drive a project that will accelerate understanding of the genetic causes of inherited retinal dystrophies (IRD).
Topical loteprednol may aid in the treatment of MGD
October 23, 2014
Patients with moderate and severe meibomian gland dysfunction (MGD) may benefit from topical loteprednol etabonate and eyelid scrubs with warm compresses, according to researchers in South Korea.
July/August 2014
Cover feature
ESCRS Showcase
A brief overview of some of the products that will be showcased during the ESCRS Congress
XXXII Congress of the ESCRS
By: Felicity Thomas, Professor Sunil Shah, Paolo Fazio, Dr Omid Kermani
The 32nd congress of the European Society of Cataract and Refractive Surgeons (ESCRS) is once again proving delectably inviting to the majority of the ophthalmology community. Not only is this the biggest event on the calendar but this year we will see it joining forces with EURETINA and EuCornea, which will surely ensure that it will be a busy and exciting congress.
Cataract and Refractive
Femtosecond laser capsulotomy and PCO development
By: Dr Illés Kovács, PhD
In this article, Dr Kov?cs discusses his recent study evaluating whether femtosecond laser-assisted capsulotomy has an effect on the incidence of PCO when compared to the manual technique.
Posterior capsule opacification in eyes with diabetes mellitus
By: Dr Mamidipudi R. Praveen, DOMS
Posterior capsule opacification (PCO) is a frequent and important complication noticed in diabetics undergoing cataract surgery, however, few studies have examined the prevalence of PCO in diabetic versus non-diabetic patients. Therefore, the authors performed a study exploring the long-term effect of diabetes on the incidence of PCO and here they highlight their findings.
Trifocal IOL facilitates intermediate vision
By: Lynda Charters, Dr Damien Gatinel, PhD
A diffractive trifocal IOL (FineVision, PhysIOL) provides a peak modulation transfer function for intermediate vision.
Alkylphosphocholine coated intraocular lenses
By: Dr Raffael Liegl, Dr Kirsten H. Eibl-Lindner, FEBO
In this article, the authors discuss their research into alkylphosphocholine coated IOLs, which may offer some hope in the prevention of PCO in the future.
Ocular nutrition: What physicians should be telling their patients
By: Nancy Groves, Dr Michael J. Cooney, MBA
The AREDS 1 and 2 studies provide important information about the role of ocular nutrition in macular degeneration. However, to benefit patients, the findings must be condensed into clear and concise advice that will help them select appropriate vitamin supplements and follow a healthy lifestyle.
The standard of care for wet AMD
By: Dr José Cunha-Vaz, Dr Roberto GallegoPinazo
To address issues around ourcomes, dosing and safety of anti-VEGFs, an independent scientific symposium (sponsored by Novartis) was held during COPHy. Here, we present some brief highlights of this meeting.
GATT novel 360? ab interno glaucoma procedure
By: Cheryl Guttman Krader, Dr Davinder S. Grover, MPH
Gonioscopy-assisted transluminal trabeculotomy is a circumferential trabeculotomy performed via a minimally invasive, ab interno approach. Results from follow-up of 6 to 12 months in a series of 85 adult eyes with uncontrolled glaucoma show high IOP lowering, along with a reduced need for medication.
A new treatment modality for corneal oedema
By: Claes Feinbaum
Currently, there is no treatment to promote the healing of endothelial cells, however, the extent of the corneal oedema can be controlled. In this article, Prof. Feinbaum discusses a new treatment option aimed at alleviating complications of visual loss and pain secondary to corneal oedema.
June 2014
Cover feature
Fighting AMD: the power of nutrition
With a greater understanding of how ocular nutrition affects sight, ophthalmologists need to encourage healthy diets with nutrients and antioxidants essential for healthy vision.
Dry AMD: A new hope
Dry age-related macular degeneration (AMD) is the most common cause of vision loss in developed countries. Although anti-VEGFs can be used to improve the quality of life for patients with the wet form of the disease there is still not much to offer dry AMD patients. In this article, Dr Georgiou highlights the results of his recent study looking at the value of higher doses of omega-3 fatty acids for this group of patients.
Anti-VEGF use in infants
Numerous trials assessing the efficacy and safety of anti-VEGFs in adults exist, however, the clinical evidence and basic science research of anti-VEGF use in infants is lacking, according to Dr Drenser. Here, she discusses what is required from future studies to justify the use of anti-VEGFs in young patients.
Outlook for integrin peptide therapy
By: Peter K. Kaiser, MD
ALG-1001 is the first of a new class of drugs, integrin peptide therapy, now going through clinical trials for patients with age-related macular degeneration, diabetic macular oedema and vitreomacular traction.
Cataract and Refractive
Weather impacts on the outcome of LASIK
Environmental factors have been discussed as possible triggers for diseases. Recently, the authors analysed the impact of seasonality and distinct meteorological parameters on refractive and visual outcome of LASIK in myopic eyes, here, they present the highlight of this study.
Optimization of toric IOL performance
By: Dr Oliver Findl
In this article, the authors discuss their study that was aimed at evaluating the rotational stability and patient visual quality of a toric IOL with a novel haptic design.
Pupil size doesn't matter, study says
By: Dr Steven C. Schallhorn
In this article, Dr Schallhorn reveals the results of a large case series that provides evidence that there is no need to reject candidates for LASIK on the basis of pupil size or to increase the treatment zone size for such patients.
How a flapless procedure provides improved optical quality
By: Cheryl Guttman Krader, Professor Dan Z. Reinstein
Results of a study comparing matched groups of eyes undergoing myopic correction by small-incision lenticule extraction (SMILE) or LASIK show that the optical quality was better and the cornea retained higher tensile strength after the flapless SMILE procedure.
New blade design for pars plana vitrectomy: A quantum leap
In this article, the authors present the highlights of their research into a new blade design for pars plana vitrectomy.
Spontaneous closure of FTMH after vitrectomy for VMT
In this article, the authors summarize a recently published case study of a macular hole formation and its spontaneous closure after vitrectomy.
Changes in the ocular surface after glaucoma therapy
Prof. Iester describes his recent study investigating whether the addition of a tear substitute would protect exposed corneal epithelial cells from damage.
Additional editorial
Managing oxygen levels in preterm infants
Findings from recent clinical trials are providing some guidance on oxygen management in preterm infants.
Ophthalmology Times Europe is the independent source for current developments and best practices in European Ophthalmology. It is the balanced and unbiased forum for ophthalmologists to communicate practical experience, clinical knowledge, discoveries and applications, thereby promoting improvements in medical medical practice and patient health.
Serving Europe's ophthalmic community


Latest Tweets
Click here